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RESULTS
DISCUSSION
Obesity not associated with metabolic syndrome is defined has metabolically healthy obesity. The prevalence is variable -
from 18 to 44%1. Certain clinical, analytic and imagiologic features are recognised in obese patients without metabolic
syndrome2. However, the pathophysiology involved remains unknown. The aim of this study was to determine the
prevalence and compare metabolically healthy obese with metabolically unhealthy obese in an obese population
undergoing bariatric surgery, with a particular focus on vitamin D.
Retrospective study that involved 217 patients followed at Braga Hospital, Endocrinology/General Surgery outpatient
consultation from 2013-2015. Metabolically healthy obesity was defined by absence of metabolic syndrome and body mass
index ≥ 30 kg/m2. Metabolic syndrome was classified according to the National Cholesterol Education Program, Adult
Treatment Panel (NCEP ATP III) updated version. Exclusion criteria: previous bariatric surgery, current supplementation with
cholecalciferol, chronic renal disease and no clinical data available. Statistic analysis: IBM® SPSS™ Statistics version 20.
Facing literature data, our study showed a superior frequency of MHO. Patients with MHO were in average 8 years younger, 
which may corroborate the theory of MHO as a transitory phenotype. Vitamin D deficiency was predominant in both groups. 
Nevertheless, we found differences in between MHO and MUHO concerning vitamin D status. These findings suggest that 
vitamin D may be relevant in metabolically healthy obesity.
47,5% (n=103) METABOLICALLY HEALTHY OBESE

























TOTAL MHO MUHO p
Sample, n 217 103 114
Female, n 183 90 93 0,266
Male, n 34 13 21 0,266
Age (years), mean±SD 41±10 37±9 45±10 < 0,001 *
BMI (kg/m2), median (IQR) 42,6 (6,8) 42,3 (6,9) 42,9 (6,9) 0,445
MHO MUHO p
25(OH)D (ng/ml) 14 12 0,023 *
Calcium (mg/dL) 9,1 9,2 0,244
Phosporus (mg/dL) 3,4 3,4 0,356
Magnesium (mg/L) 19 18 0,043 *
Albumine (g/dL) 3,9 3,9 0,763
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Deficiency ≤ 20 ng/mL
Graphic 2. VITAMIN D STATUS
n
%
HOMA-IR was superior in the MUHO group  (p<0,001)
Legend:
MHO – Metabolically healthy obesity. MUHO – Metabolically unhealthy obesity. 
OSA – Obstructive Sleep Apnea
p significance level of 0.05. Marked with * if statistically significant
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